NCT07056439View on ClinicalTrials.gov

Phase I/II Clinical Study of HRS-1738 for the Diagnosis of Prostate Cancer Patients

PHASE1/PHASE2Not yet recruitingINTERVENTIONAL

Enrollment

50

Participants

Timeline

Start Date

July 31, 2025

Primary Completion Date

August 31, 2026

Study Completion Date

August 31, 2026

Conditions

PET Imaging in Patients With Prostate Cancer

Interventions

DRUG

HRS-1738 Injection

HRS-1738 injection.

Trial Locations (1)

100142

Beijing Cancer Hospital, Beijing

All Listed Sponsors

lead

Jiangsu HengRui Medicine Co., Ltd.

INDUSTRY